Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval Zonisade™ (zonisamide oral suspension) – New Drug Approval – July 18, 2022 – Azurity Pharmaceuticals, Inc., a private pharmaceutical company focused on developing innovative products to serve the specific needs…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval No new update. New Indication/Dosage/Formulation Approval  Comirnaty® (COVID-19 Vaccine, mRNA) Injection – New Label Expansion – July 8, 2022 – Pfizer Inc. and BioNTech SE announced the U.S. Food…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval No new update. New Indication/Dosage/Formulation Approval Qsymia® (phentermine and topiramate) Extended-Release Capsules – New Label Expansion – June 24, 2022 – The U.S. Food and Drug Administration has approved…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval No new update. New Indication/Dosage/Formulation Approval Breyanzi® (lisocabtagene maraleucel) – New Label Expansion – June 24, 2022 – The Food and Drug Administration approved lisocabtagene maraleucel (Breyanzi®, Juno Therapeutics,…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval No new update. New Indication/Dosage/Formulation Approval Imcivree® (setmelanotide) Injection – New Approved Indication – June 16, 2022 – Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company committed to transforming the…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug/Vaccine Approval Amvuttra™ (vutrisiran) – New Drug Approval – June 13, 2022 – Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced that the U.S. Food and Drug Administration (FDA) approved…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval No new update. New Indication/Dosage/Formulation Approval No new update. New Drug Shortage June 03, 2022 Nystatin Ointment (Discontinuation) Updated Drug Shortage June 06, 2022 Iodixanol (Visipaque) Injection (Currently in…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Enjaymo™ (sutimlimab-jome) Injection – New Drug Approval – February 4, 2022 – FDA has approved Enjaymo™ (sutimlimab-jome) infusion to decrease the need for red blood cell transfusion due…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Vabysmo™ (faricimab-svoa) Intravitreal Injection – New Drug Approval – January 28, 2022 – Roche announced that the U.S. Food and Drug Administration (FDA) has approved Vabysmo™ (faricimab-svoa) for…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Ryaltris™ Nasal Spray – New Drug Approval – January 14, 2022 – Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced that its fully owned subsidiary Glenmark…

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Cibinqo® (abrocitinib) Tablets – New Drug Approval – January 14, 2022 – Pfizer Inc. announced that the United States (U.S.) Food and Drug Administration (FDA) approved Cibinqo® (abrocitinib),…